Charles River plots 2020 opening of South San Francisco lab

Charles River
The new Charles River Accelerator and Development Lab in South San Francisco will sister its site in Cambridge, Massachusetts. (Charles River)

Charles River Laboratories International has penned “early 2020” for the opening of its Charles River Accelerator and Development Lab (aka CRADL) in South San Francisco.

This lab is slated to provide “flexible, turnkey vivarium rental space supported by Charles River’s technical, vivarium, and veterinary support expertise in key biohubs,” according to the biopharma services provider.

The rentals are designed to be offered out to pharma and biotech researchers to launch or expand their drug research programs. But more than at your average lab, clients also gain access to Charles River’s complete portfolio of integrated drug discovery resources.

Webinar

De-risking the Development of Biotherapeutics Using Early Stage In Vitro Expression and Genetic Characterisation Tools

There is a high attrition rate during the development of biotherapeutics impacting the high cost of development. Early identification of the preferred expression host for manufacturing, along with lead candidate screening and material supply can help to reduce both attrition rates and cost.

“Managed by skilled technicians, every research model receives best-in-class care in secure, modern, regulatory-compliant facilities," the company says.

It has a similar and older setup in downtown Cambridge, Massachusetts, which offers rental vivarium space for emerging and well-established research institutions.

RELATED: Charles River Labs cuts jobs as it closes San Diego site

Charles River says, similar to its sister facility in Cambridge, CRADL South San Francisco will “focus on providing a turnkey vivarium solution and in vivo support services for researchers looking to divert more time and resources to their research.”  

Birgit Girshick, corporate executive vice president for discovery and safety assessment, biologics testing solutions and avian vaccine services at Charles River, said: “In the earliest days of research, reaching key milestones on time and on budget is paramount to a program’s success. CRADL offers researchers the ability to focus on their research. When clients are ready to progress their idea through the development pipeline, Charles River has the portfolio and scientific expertise to offer critical support.”

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

The supermarket chain received an emergency authorization for its own home collection kit for COVID-19 testing, which includes a telehealth consult.